Alt Text From Webb Telescope and Metformin Clinical Trial For Stargardt Disease On August 21 Show

Tim Rhue (Space Telescope Institute - Baltimore, MD)

Dr. Brian Brooks (National Eye Institute - Bethesda, MD)

Tim Rhue, principal informal education specialist, and Margaret Carruthers, writing and design deputy, of the Space Telescope Science Institute in Baltimore, explain the process by which the alt text descriptions explaining the images from the James Webb Space Telescope were written.

Then, Dr. Brian Brooks, branch chief of Ophthalmic Genetics and Visual Function branch of the National Eye Institute in Bethesda, Maryland, goes over a clinical trial, involving a drug, metformin, which potentially could slow the progression of photoreceptor death in Stargardt Disease.

August 21 Podcast (Click Image Below) 

Loss Of "Youth" Protein Drives Aging of Eyes In Mice And OcuMet Beacon Used To Detect Fluorescence To Diagnose Glaucoma Early On August 7 Show

Dr. Patricia Becerra (National Eye Institute - Bethesda, MD)

Dr. Richard Rosen (Mount Sinai Health System - New York, NY)

Dr.  Patricia Becerra, chief of the National Eye Institute Section on Protein Structure and Function, discusses how loss of the "youth" protein, pigment epithelium-derived factor (PEDF), drives aging of the eye in mice.

Then, Dr. Richard Rosen, Pierce Distinguished Professor of Ophthalmology and Retinal Service Chief of the Mount Sinai Health System in New York, explains how the OcuMet Beacon camera with special filters that specifically isolate fluorescence detect flavoprotein fluorescence (FPF), which is an indicator of mitochondrial oxidative stress and early sign of glaucoma.

8/7/2022 Podcast (Click Image Below)